For the Inventor, By the Inventor

Enter inventor name

New York, NY, United States of America

Eric L Smith

USPTO Granted Patents = 85 (Patent Applications = 51)

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 3.8

ph-index = 14

Forward Citations = 896(Granted Patents)

Forward Citations (Not Self Cited) = 811(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hagerstown, MD (US) (1982 - 1994)
North Richland Hills, TX (US) (1999)
Sarver, PA (US) (2015)
New York, NY (US) (2009 - 2024)

Company Filing History:

56 out of 1,343

Regeneron Pharmaceuticals, Inc.

Memorial Sloan Kettering Cancer Center

Eureka Therapeutics, Inc.

Regeneran Pharmaceuticals, Inc.

Juno Therapeutics Gmbh

6. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptors

Bispecific Antibodies

Cytokine Release Syndrome

Nucleic Acid Molecules

Antigen Binding Molecules

IL2 Agonists

Tumor Treatment

Humanized CD3 Complex

Anti-PSMA Antibodies

Cell Targeting

Immunoglobulin Format

Antibody-Drug Conjugates

85 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),

2. 12391753 - Antigen binding molecule formats (2025-08-19),

3. 12344677 - Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof (2025-07-01),

4. 12331109 - Antigen binding molecule formats (2025-06-17),

5. 12319724 - IL2 agonists and methods of use thereof (2025-06-03),

6. 12274747 - Compositions and methods for treating cytokine release syndrome (2025-04-14),

7. 12258412 - Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies (2025-03-25),

8. 12215148 - Antigen binding molecule formats (2025-02-04),

9. 12215131 - IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof (2025-02-04),

10. 12180272 - Antigen binding molecule formats (2024-12-31),

11. 12157758 - Readily isolated bispecific antibodies with native immunoglobulin format (2024-12-03),

12. 12139538 - Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereof (2024-11-12),

13. 12091440 - IL2 and peptide-MHC complex fusion proteins and methods of use thereof (2024-09-17),

14. 12077603 - Multispecific antigen-binding molecules for cell targeting and uses thereof (2024-09-03),

15. 12065508 - Multispecific antigen-binding molecules for cell targeting and uses thereof (2024-08-20),

Title: The Inventor Profile of Eric L Smith

Introduction: Eric L Smith is a prolific inventor based in New York, NY, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Eric L Smith holds several patents in diverse areas such as technology, healthcare, and consumer products, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Eric L Smith has established himself as a leading figure in the world of innovation, with numerous successful inventions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Eric L Smith has collaborated with top research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Eric L Smith's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…